Ann Kramer

Ann graduated from the University of Cambridge with a degree in Natural Sciences and joined ICI Agrochemicals. Over almost 20 years with ICI, Zeneca and Syngenta she gained experience across the business including in research, sales, business development and M&A, with roles in the UK, USA and Switzerland. She managed the development of genetically modified food business streams in fresh produce crops. Since 2006 she has worked in the SME sector in the UK as Head of Business development for Oxitec Ltd. (acquired by Intrexon in 2015), COO of Immunocore Ltd. and CEO of Biosyntha Ltd. She joined The Electrospinning Company as CEO in 2012.

Ann Kramer is the CEO at The Electrospinning Company, based in Europe. With a background in 3D Technology, Ann Kramer has a rich history of leadership and innovation.Ann Kramer studied MA Natural Sciences at University of Cambridge. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.